The safe use of percutaneous gastrostomy for enteral nutrition in patients with Crohn's diseaseANSTEE, Quentin M; FORBES, Alastair.European journal of gastroenterology & hepatology. 2000, Vol 12, Num 10, pp 1089-1093, issn 0954-691XArticle

Mouse models in non-alcoholic fatty liver disease and steatohepatitis researchANSTEE, Quentin M; GOLDIN, Robert D.International journal of experimental pathology. 2006, Vol 87, Num 1, pp 1-16, issn 0959-9673, 16 p.Article

How big a problem is non-alcoholic fatty liver disease?ANSTEE, Quentin M; MCPHERSON, Stuart; DAY, Christopher P et al.BMJ (Overseas and retired doctors ed.). 2011, Vol 343, Num 7816, pp 201-204, issn 1759-2151, 4 p.Article

The role of hypercoagulability in liver fibrogenesisANSTEE, Quentin M; DHAR, Ameet; THURSZ, Mark R et al.Clinics and research in hepatology and gastroenterology (Print). 2011, Vol 35, Num 8-9, pp 526-533, issn 2210-7401, 8 p.Article

S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utilityANSTEE, Quentin M; DAY, Christopher P.Journal of hepatology. 2012, Vol 57, Num 5, pp 1097-1109, issn 0168-8278, 13 p.Article

Investigating mildly abnormal serum aminotransferase valuesCOBBOLD, Jeremy F. L; ANSTEE, Quentin M; THOMAS, Howard C et al.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7767, pp 297-299, issn 1759-2151, 3 p.Article

Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to TreatmentDONGIOVANNI, Paola; ANSTEE, Quentin M; VALENTI, Luca et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 29, pp 5219-5238, issn 1381-6128, 20 p.Article

Symposium 5 (Joint Nutrition Society and BAPEN Symposium): Too many pies: metabolic competencies in obesity The importance of fatty liver disease in clinical practiceCOBBOLD, Jeremy F. L; ANSTEE, Quentin M; TAYLOR-ROBINSON, Simon D et al.Proceedings of the Nutrition Society. 2010, Vol 69, Num 4, pp 518-527, issn 0029-6651, 10 p.Conference Paper

The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studiesAL-SERRI, Ahmad; ANSTEE, Quentin M; DALY, Ann K et al.Journal of hepatology. 2012, Vol 56, Num 2, pp 448-454, issn 0168-8278, 7 p.Article

Phenotyping murine models of non-alcoholic fatty liver disease through metabolic profiling of intact liver tissueCOBBOLD, Jeremy F. L; ANSTEE, Quentin M; TAYLOR-ROBINSON, Simon D et al.Clinical science (1979). 2009, Vol 116, Num 5-6, pp 403-413, issn 0143-5221, 11 p.Article

Quantifying hepatic steatosis ― more than meets the eyeLEVENE, Adam P; KUDO, Hiromi; ARMSTRONG, Matthew J et al.Histopathology. 2012, Vol 60, Num 6, pp 971-981, issn 0309-0167, 11 p.Article

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitisANSTEE, Quentin M; CONCAS, Danilo; KUDO, Hiromi et al.Journal of hepatology. 2010, Vol 53, Num 3, pp 542-550, issn 0168-8278, 9 p.Article